SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-050753
Filing Date
2024-06-07
Accepted
2024-06-07 16:00:43
Documents
14
Period of Report
2024-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0207524-8k_optimize.htm   iXBRL 8-K 39457
2 AMENDMENT NO. 1 TO THE OPTIMIZERX 2021 EQUITY INCENTIVE PLAN ea0207524ex10-1_optimize.htm EX-10.1 5270
  Complete submission text file 0001213900-24-050753.txt   221761

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE oprx-20240605.xsd EX-101.SCH 3021
4 XBRL LABEL FILE oprx-20240605_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE oprx-20240605_pre.xml EX-101.PRE 22363
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0207524-8k_optimize_htm.xml XML 3671
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 241029153
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)